Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

"Try to remember how you felt in September 2008, right when you learned Lehman collapsed. Were you more scared then, or are you more scared now?"

The intrigue: That's a question I've been asking investors and other sources since late February. When I began, the responses were pretty evenly split.

  • This week, all but two people said they are more scared now — and that majority includes several big names who were previously siding with 2008.

The argument in favor of 2008 being scarier is that no one knew if the pit had a bottom, or if we'd just spiral endlessly — vacuuming up Main Street after Wall Street.

  • Our present slide, while horrific, will eventually end — if not because of social distancing, then because scientists discover treatments and/or vaccines.

The argument for 2020 is that Main Street and much of Corporate America are being eviscerated simultaneously.

  • Wall Street may be relatively immune so far, outside of plunging equity prices and M&A fee interruptions, but Wall Street is just a lubricant for the American economy — it's not the pistons. And if we begin to see a large wave of corporate defaults, both Wall Street and private equity will feel a suffocating squeeze of their own.
  • Add to this the fear of sickness and death, particularly for older Americans, neither of which we experienced in 2008.

The bottom line: While we are always captive to the present, it is objectively reasonable to call this the most fraught moment of our collective lives. Decisions that get made over the next several days and weeks, including the White House's $1 trillion stimulus proposal that many think is too small, will be consequential for most everything ever again covered in this newsletter, or in media like it.

Go deeper

USAID chief tests positive for coronavirus

An Air Force cargo jet delivers USAID supplies to Russia earlier this year. Photo: Mikhail Metzel/TASS via Getty Images

The acting administrator of the United States Agency for International Development informed senior staff Wednesday he has tested positive for coronavirus, two sources familiar with the call tell Axios.

Why it matters: John Barsa, who staffers say rarely wears a mask in their office, is the latest in a series of senior administration officials to contract the virus. His positive diagnosis comes amid broader turmoil at the agency following the election.

Bryan Walsh, author of Future
5 hours ago - Health

COVID-19 shows a bright future for vaccines

Illustration: Annelise Capossela/Axios

Promising results from COVID-19 vaccine trials offer hope not just that the pandemic could be ended sooner than expected, but that medicine itself may have a powerful new weapon.

Why it matters: Vaccines are, in the words of one expert, "the single most life-saving innovation ever," but progress had slowed in recent years. New gene-based technology that sped the arrival of the COVID vaccine will boost the overall field, and could even extend to mass killers like cancer.

7 hours ago - Health

Beware a Thanksgiving mirage

Illustration: Sarah Grillo/Axios

Don't be surprised if COVID metrics plunge over the next few days, only to spike next week.

Why it matters: The COVID Tracking Project warns of a "double-weekend pattern" on Thanksgiving — where the usual weekend backlog of data is tacked on to a holiday.